Health Catalyst reports Q4 revenue down 6% YoY; net loss widens to $91M

Health Catalyst, Inc.

Full-year 2025 revenue $311.1M, up 1% YoY; Q4 revenue $74.7M, down 6% YoY.
Q4 net loss $91.0M vs $20.7M in Q4 2024; full-year net loss $178.0M vs $69.5M.
Adjusted EBITDA for full-year 2025 was $41.4M.
CEO Ben Albert cited opportunities and areas for improvement; focused on long-term success.

item 2.02 item 9.01

Key facts

Extracted from this filing and checked against the source text.

Earnings Releases SEC 8-K Item 2.02 confidence 0.9

Health Catalyst, Inc. reported the quarter ended December 31, 2025 results: revenue $ 74,679, net income $ (91,025).

Period: the quarter ended December 31, 2025
Revenue: $ 74,679
Net income: $ (91,025)
Result: reported results

Exact text from the filing

Months Ended December 31, Year over Year Change 2025 2024 2025 2024 GAAP Financial Measures: (in thousands, except percentages) (in thousands, except percentages) Total revenue $ 74,679 $ 79,606 (6)% $ 311,136 $ 306,584 1% Gross profit $ 31,385 $ 28,618 10% $ 120,356 $ 114,503 5% Gross margin 42.0 % 35.9 % 38.7 % 37.3 % Net loss $ (91,025) $ (20,673) (340)% $

View on SEC.gov

Earnings Releases SEC 8-K Item 2.02 confidence 0.9

Health Catalyst, Inc. reported the year ended December 31, 2025 results: revenue $311.1 million, net income $ (177,974).

Period: the year ended December 31, 2025
Revenue: $311.1 million
Net income: $ (177,974)
Result: reported results

Exact text from the filing

We closed 2025 with solid performance across our business, including total revenue of $311.1 million and Adjusted EBITDA of $41.4 million,

View on SEC.gov

44 earnings releases filed in the last 30 days. Browse all earnings releases →

Health Catalyst, Inc. filing history →

Source: SEC EDGAR

accession 0001636422-26-000031

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.